Get started

Seqirus (Australia)

Alternate names: CSL Seqirus, Seqirus (Australia) Pty Ltd
Parent institution: CSL (Australia)
ROR: 03qptmm33
OpenAlex ID: I4405280994
The structure of the influenza A virus genome
2019 · Bernadeta Dadonaite, Brad Gilbertson, et al. · Nature Microbiology · 288
PDF
Human CD8+ T cell cross-reactivity across influenza A, B and C viruses
2019 · Marios Koutsakos, Patricia T. Illing, et al. · Nature Immunology · 247
PDF
Circulating T FH cells, serological memory, and tissue compartmentalization shape human influenza-specific B cell immunity
2018 · Marios Koutsakos, Adam K. Wheatley, et al. · Science Translational Medicine · 228
Influenza lineage extinction during the COVID-19 pandemic?
2021 · Marios Koutsakos, Adam K. Wheatley, et al. · Nature Reviews Microbiology · 191
PDF
Safety, immunogenicity, and efficacy of a COVID-19 vaccine (NVX-CoV2373) co-administered with seasonal influenza vaccines: an exploratory substudy of a randomised, observer-blinded, placebo-controlled, phase 3 trial
2021 · Seth Toback, Eva Galiza, et al. · The Lancet Respiratory Medicine · 158
PDF
Safety, tolerability, acceptability and immunogenicity of an influenza vaccine delivered to human skin by a novel high-density microprojection array patch (Nanopatch™)
2018 · Germain J.P. Fernando, Julian Hickling, et al. · Vaccine · 130
PDF
Safety, tolerability, and immunogenicity of influenza vaccination with a high-density microarray patch: Results from a randomized, controlled phase I clinical trial
2020 · Angus H. Forster, Katey Witham, et al. · PLoS Medicine · 104
PDF
Downregulation of MHC Class I Expression by Influenza A and B Viruses
2019 · Marios Koutsakos, Hamish E. G. McWilliam, et al. · Frontiers in Immunology · 99
PDF
What Lies Beneath: Antibody Dependent Natural Killer Cell Activation by Antibodies to Internal Influenza Virus Proteins
2016 · Hillary A. Vanderven, Fernanda Ana-Sosa-Batiz, et al. · EBioMedicine · 76
PDF
Chemometric Analysis of Lavender Essential Oils Using Targeted and Untargeted GC-MS Acquired Data for the Rapid Identification and Characterization of Oil Quality
2017 · David J. Beale, Paul D. Morrison, et al. · Molecules · 72
PDF
Which influenza viruses will emerge following the SARS‐CoV‐2 pandemic?
2021 · Karen L. Laurie, Steve Rockman · Influenza and Other Respiratory Viruses · 68
PDF
Survey of distribution of seasonal influenza vaccine doses in 201 countries (2004–2015): The 2003 World Health Assembly resolution on seasonal influenza vaccination coverage and the 2009 influenza pandemic have had very little impact on improving influenza control and pandemic preparedness
2017 · A. Palache, A. Abelin, et al. · Vaccine · 60
New Technologies for Influenza Vaccines
2020 · Steven Rockman, Karen L. Laurie, et al. · Microorganisms · 58
PDF
Prevention of influenza during mismatched seasons in older adults with an MF59-adjuvanted quadrivalent influenza vaccine: a randomised, controlled, multicentre, phase 3 efficacy study
2021 · Jiří Beran, Humberto Reynales, et al. · The Lancet Infectious Diseases · 50
Influenza NA and PB1 Gene Segments Interact during the Formation of Viral Progeny: Localization of the Binding Region within the PB1 Gene
2016 · Brad Gilbertson, Tian Zheng, et al. · Viruses · 50
PDF
The metabolic hormone leptin promotes the function of TFH cells and supports vaccine responses
2021 · Jun Deng, Qian Chen, et al. · Nature Communications · 48
PDF
CD8+ T cell landscape in Indigenous and non-Indigenous people restricted by influenza mortality-associated HLA-A*24:02 allomorph
2021 · Luca Hensen, Patricia T. Illing, et al. · Nature Communications · 46
PDF
Cell-Based Manufacturing Technology Increases Antigenic Match of Influenza Vaccine and Results in Improved Effectiveness
2022 · Steven Rockman, Karen Laurie, et al. · Vaccines · 45
PDF
HLA-A*11:01-restricted CD8+ T cell immunity against influenza A and influenza B viruses in Indigenous and non-Indigenous people
2022 · Jennifer R. Habel, Andrea T. Nguyen, et al. · PLoS Pathogens · 37
Vaccine complacency and dose distribution inequities limit the benefits of seasonal influenza vaccination, despite a positive trend in use
2021 · Abraham Palache, Steven Rockman, et al. · Vaccine · 37
Immune imprinting in early life shapes cross-reactivity to influenza B virus haemagglutinin
2024 · Peta Edler, Lara S. U. Schwab, et al. · Nature Microbiology · 36
PDF
Post hoc analysis of reactogenicity trends between dose 1 and dose 2 of the adjuvanted recombinant zoster vaccine in two parallel randomized trials
2020 · Romulo Colindres, Valentine Wascotte, et al. · Human Vaccines & Immunotherapeutics · 36
PDF
Immunogenicity and safety of a quadrivalent inactivated influenza vaccine compared with two trivalent inactivated influenza vaccines containing alternate B strains in adults: A phase 3, randomized noninferiority study
2017 · John T. Treanor, Frank R. Albano, et al. · Vaccine · 35
PDF
Intravenous Immunoglobulin Protects Against Severe Pandemic Influenza Infection
2017 · Steven Rockman, Sue Lowther, et al. · EBioMedicine · 34
PDF
Co-Administration of Influenza and COVID-19 Vaccines: Policy Review and Vaccination Coverage Trends in the European Union, UK, US, and Canada between 2019 and 2023
2024 · Roel C. A. Achterbergh, Ian McGovern, et al. · Vaccines · 32
PDF
Works count: 125
Citation count: 4,829
Year
Topic
Type